Story
Formycon Boosts H1 Revenue to €25.8M, Narrows EBITDA Loss on Biosimilar Progress

German biosimilar developer Formycon AG (FYB) announced a significant increase in first-half revenue and a narrower loss, according to its latest financial report. The company's improved performance was driven by key partnership payments related to its drug pipeline and a reduction in research expenses.
H1 Financial Performance
For the first six months of 2026, Formycon posted strong top-line growth and a notable improvement in profitability.
- Revenue: Reached €25.8 million, a sharp increase from the prior-year period.
- EBITDA Loss: Narrowed to €3.4 million, reflecting an improvement from the loss recorded in the first half of the previous year.
This positive trend was attributed to a combination of higher income and more efficient cost management, according to the company's filing.
Revenue Drivers and Cost Controls
AdThe revenue surge was primarily fueled by milestone and upfront payments from commercialization and development partnerships for its FYB206 biosimilar. Formycon also recorded increased royalty income and milestone payments from its FYB202 product, despite what it described as challenging market conditions.
The narrower loss was supported by lower research and development (R&D) costs. The company stated that these expenses declined as projects progressed through the development cycle, allowing for the capitalization of certain costs. During the period, Formycon also successfully completed clinical development for FYB206.
Full-Year Guidance Reaffirmed
Following its first-half results, Formycon confirmed its financial outlook for the full year 2026. The company projects its full-year revenue to be between €60 million and €70 million.
Group EBITDA for 2026 is expected to land in a range between €0 million and €10 million. Management anticipates that milestone payments for FYB206 and ongoing royalty income from FYB202 will be the main revenue drivers for the second half of the year.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.